|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
22-2590301
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification Number)
|
Large accelerated filer
|
¨
|
Accelerated filer
|
¨
|
|
|
|
|
Non-accelerated filer
|
x (Do not check if a smaller reporting company)
|
Smaller reporting company
|
¨
|
|
|
|
Page
|
PART I. FINANCIAL INFORMATION
|
||
Item 1.
|
|
|
|
||
|
||
|
||
|
||
|
||
Item 2.
|
||
Item 3.
|
||
Item 4.
|
||
|
|
|
PART II. OTHER INFORMATION
|
||
Item 1.
|
||
Item 1A.
|
||
Item 2.
|
||
Item 3.
|
||
Item 4.
|
||
Item 5.
|
||
Item 6.
|
||
|
March 31,
|
|
December 31,
|
||||
|
2016
|
|
2015
|
||||
Assets
|
|
|
|
||||
Current assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
17,599,856
|
|
|
$
|
17,854,523
|
|
Accounts receivable, net
|
15,250,744
|
|
|
18,308,547
|
|
||
Unbilled receivables
|
302,424
|
|
|
1,024,861
|
|
||
Deferred commissions
|
3,805,502
|
|
|
3,767,432
|
|
||
Prepaid expenses and other current assets
|
2,608,900
|
|
|
2,003,849
|
|
||
Total current assets
|
39,567,426
|
|
|
42,959,212
|
|
||
Property and equipment, net
|
11,712,563
|
|
|
12,180,109
|
|
||
Goodwill
|
43,904,616
|
|
|
43,913,185
|
|
||
Other intangibles, net
|
7,290,001
|
|
|
7,673,661
|
|
||
Deferred commissions
|
6,578,094
|
|
|
7,007,518
|
|
||
Deposits and other assets
|
777,262
|
|
|
890,059
|
|
||
Total assets
|
$
|
109,829,962
|
|
|
$
|
114,623,744
|
|
Liabilities and Stockholders’ Equity
|
|
|
|
||||
Current liabilities:
|
|
|
|
||||
Accounts payable
|
$
|
1,553,483
|
|
|
$
|
1,451,463
|
|
Accrued expenses
|
9,450,025
|
|
|
8,805,159
|
|
||
Current portion of capital lease obligations
|
1,559,760
|
|
|
1,598,450
|
|
||
Deferred revenue
|
31,487,108
|
|
|
30,532,404
|
|
||
Current portion of term loan, net of discount and debt financing costs
|
312,086
|
|
|
312,086
|
|
||
Total current liabilities
|
44,362,462
|
|
|
42,699,562
|
|
||
Capital lease obligations, less current portion
|
1,554,503
|
|
|
1,916,944
|
|
||
Deferred revenue, less current portion
|
2,338,639
|
|
|
2,393,345
|
|
||
Term loan, net of discount and debt financing costs, less current portion
|
14,129,829
|
|
|
14,207,850
|
|
||
Revolving credit facility
|
3,250,000
|
|
|
5,000,000
|
|
||
Other noncurrent liabilities
|
4,423,028
|
|
|
3,909,728
|
|
||
Total liabilities
|
70,058,461
|
|
|
70,127,429
|
|
||
Commitments and contingencies (Note 11)
|
|
|
|
|
|
||
Stockholders’ equity:
|
|
|
|
||||
Common stock, $0.001 par value; 100,000,000 shares authorized; issued and outstanding 26,346,987 and 26,260,459 shares at March 31, 2016 and December 31, 2015, respectively
|
26,347
|
|
|
26,261
|
|
||
Additional paid-in capital
|
182,941,280
|
|
|
181,457,089
|
|
||
Accumulated other comprehensive loss
|
(1,306,117
|
)
|
|
(783,209
|
)
|
||
Accumulated deficit
|
(141,890,009
|
)
|
|
(136,203,826
|
)
|
||
Total stockholders’ equity
|
39,771,501
|
|
|
44,496,315
|
|
||
Total liabilities and stockholders’ equity
|
$
|
109,829,962
|
|
|
$
|
114,623,744
|
|
|
Three Months Ended
|
||||||
|
March 31,
|
||||||
|
2016
|
|
2015
|
||||
Revenue:
|
|
|
|
||||
Subscription
|
$
|
12,438,984
|
|
|
$
|
10,341,350
|
|
Professional services
|
4,525,688
|
|
|
4,852,775
|
|
||
Total revenue
|
16,964,672
|
|
|
15,194,125
|
|
||
Cost of revenue (1):
|
|
|
|
||||
Cost of subscription revenue
|
5,049,875
|
|
|
4,388,240
|
|
||
Cost of professional services revenue
|
3,967,701
|
|
|
3,816,518
|
|
||
Total cost of revenue
|
9,017,576
|
|
|
8,204,758
|
|
||
Gross profit
|
7,947,096
|
|
|
6,989,367
|
|
||
Operating expenses (1):
|
|
|
|
||||
Sales and marketing
|
5,495,541
|
|
|
5,715,141
|
|
||
Research and development
|
3,887,996
|
|
|
3,625,719
|
|
||
General and administrative
|
3,998,636
|
|
|
4,383,423
|
|
||
Total operating expenses
|
13,382,173
|
|
|
13,724,283
|
|
||
Loss from operations
|
(5,435,077
|
)
|
|
(6,734,916
|
)
|
||
Interest income
|
21,628
|
|
|
11,948
|
|
||
Interest expense
|
(200,380
|
)
|
|
(124,933
|
)
|
||
Loss before income taxes
|
(5,613,829
|
)
|
|
(6,847,901
|
)
|
||
Income tax expense
|
72,354
|
|
|
102,275
|
|
||
Net loss
|
$
|
(5,686,183
|
)
|
|
$
|
(6,950,176
|
)
|
|
|
|
|
||||
Net loss per common share (Note 10):
|
|
|
|
||||
Basic and diluted
|
$
|
(0.22
|
)
|
|
$
|
(0.27
|
)
|
Weighted-average common shares outstanding (Note 10):
|
|
|
|
||||
Basic and diluted
|
26,440,343
|
|
|
25,959,332
|
|
|
|
Three Months Ended
|
||||||
|
March 31,
|
||||||
|
2016
|
|
2015
|
||||
Net loss
|
$
|
(5,686,183
|
)
|
|
$
|
(6,950,176
|
)
|
Other comprehensive loss:
|
|
|
|
||||
Foreign currency translation
|
(522,908
|
)
|
|
(51,667
|
)
|
||
Total other comprehensive loss
|
(522,908
|
)
|
|
(51,667
|
)
|
||
Comprehensive loss
|
$
|
(6,209,091
|
)
|
|
$
|
(7,001,843
|
)
|
|
Three Months Ended
|
||||||
|
March 31,
|
||||||
|
2016
|
|
2015
|
||||
Cash flows from operating activities:
|
|
|
|
||||
Net loss
|
$
|
(5,686,183
|
)
|
|
$
|
(6,950,176
|
)
|
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
|
|
|
|
||||
Depreciation and amortization
|
1,683,162
|
|
|
1,556,956
|
|
||
Bad debt expense
|
174,221
|
|
|
1,261
|
|
||
Stock-based compensation
|
1,348,521
|
|
|
1,717,299
|
|
||
Compensation related to puttable common stock
|
—
|
|
|
13,691
|
|
||
Acquisition related deferred compensation
|
283,977
|
|
|
—
|
|
||
Changes in fair value of contingent consideration liability
|
(20,000
|
)
|
|
(287,441
|
)
|
||
Non-cash interest expense related to debt
|
—
|
|
|
58,644
|
|
||
Amortization of debt financing costs and accretion of debt discount
|
15,729
|
|
|
9,060
|
|
||
Changes in operating assets and liabilities:
|
|
|
|
||||
Accounts receivable
|
2,886,825
|
|
|
2,337,994
|
|
||
Unbilled receivables
|
721,950
|
|
|
(360,182
|
)
|
||
Prepaid expenses and other assets
|
(215,749
|
)
|
|
(490,462
|
)
|
||
Accounts payable
|
71,753
|
|
|
(397,589
|
)
|
||
Accrued expenses
|
671,913
|
|
|
(2,208,237
|
)
|
||
Other liabilities
|
220,323
|
|
|
375,352
|
|
||
Deferred revenue
|
897,943
|
|
|
1,602,165
|
|
||
Net cash provided by (used in) operating activities
|
3,054,385
|
|
|
(3,021,665
|
)
|
||
Cash flows from investing activities:
|
|
|
|
||||
Capital expenditures
|
(87,003
|
)
|
|
(110,241
|
)
|
||
Addition of capitalized software development costs
|
(721,048
|
)
|
|
(254,755
|
)
|
||
Addition of intangible assets
|
—
|
|
|
(550,000
|
)
|
||
Acquisition, net of cash acquired
|
—
|
|
|
(25,593,426
|
)
|
||
Cash received (paid) for deposits
|
—
|
|
|
(992
|
)
|
||
Decrease in restricted cash
|
113,094
|
|
|
—
|
|
||
Net cash used in investing activities
|
(694,957
|
)
|
|
(26,509,414
|
)
|
||
Cash flows from financing activities:
|
|
|
|
||||
Proceeds from revolving line of credit
|
3,250,000
|
|
|
—
|
|
||
Payments on revolving line of credit
|
(5,000,000
|
)
|
|
—
|
|
||
Proceeds from term loan
|
—
|
|
|
20,000,000
|
|
||
Payments on term loan
|
(93,750
|
)
|
|
—
|
|
||
Debt discount and financing costs
|
—
|
|
|
(183,854
|
)
|
||
Repayments on capital lease obligations
|
(401,131
|
)
|
|
(369,700
|
)
|
||
Proceeds from the exercise of stock options
|
135,756
|
|
|
986,182
|
|
||
Net cash provided by (used in) financing activities
|
(2,109,125
|
)
|
|
20,432,628
|
|
||
Effect of exchange rate on cash and cash equivalents
|
(504,970
|
)
|
|
(46,455
|
)
|
||
Net decrease in cash and cash equivalents
|
(254,667
|
)
|
|
(9,144,906
|
)
|
||
Cash and cash equivalents at beginning of period
|
17,854,523
|
|
|
41,242,200
|
|
||
Cash and cash equivalents at end of period
|
$
|
17,599,856
|
|
|
$
|
32,097,294
|
|
|
|
|
|
||||
Supplemental disclosures of cash flow information:
|
|
|
|
||||
Cash paid for interest
|
167,800
|
|
|
61,182
|
|
||
Non-cash property and equipment acquired under capital lease
|
—
|
|
|
618,946
|
|
||
Non-cash property and equipment and intangible asset purchases in accounts payable
|
27,681
|
|
|
35,683
|
|
||
Non-cash acquisition contingent consideration
|
—
|
|
|
2,251,000
|
|
(1)
|
Background
|
(2)
|
Summary of Significant Accounting Policies and Practices
|
|
March 31,
|
|
December 31,
|
||||
|
2016
|
|
2015
|
||||
Cash and cash equivalents
|
$
|
17,373,496
|
|
|
$
|
17,741,387
|
|
Money market accounts
|
226,360
|
|
|
113,136
|
|
||
|
$
|
17,599,856
|
|
|
$
|
17,854,523
|
|
Market Approach
|
— Prices and other relevant information generated by market transactions involving identical or comparable assets and liabilities;
|
Income Approach
|
— Techniques to convert future amounts to a single present amount based on market expectations (including present value techniques and option pricing models); and
|
Cost Approach
|
— Amount that currently would be required to replace the service capacity of an asset (often referred to as replacement cost).
|
|
Fair Value Measurements at Reporting Date Using
|
||||||||||||||
March 31, 2016
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||
Assets:
|
|
|
|
|
|
|
|
||||||||
Cash equivalents - money market accounts
|
$
|
226,360
|
|
|
$
|
226,360
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Restricted cash - money market accounts
|
56,141
|
|
|
56,141
|
|
|
—
|
|
|
—
|
|
||||
Total assets measured at fair value on a recurring basis
|
$
|
282,501
|
|
|
$
|
282,501
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Liabilities:
|
|
|
|
|
|
|
|
||||||||
Acquisition contingent consideration liability
|
$
|
1,239,531
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,239,531
|
|
Total liabilities measured at fair value on a recurring basis
|
$
|
1,239,531
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,239,531
|
|
|
|
|
|
|
|
|
|
||||||||
December 31, 2015
|
|
|
|
|
|
|
|
||||||||
Assets:
|
|
|
|
|
|
|
|
||||||||
Cash equivalents - money market accounts
|
$
|
113,136
|
|
|
$
|
113,136
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Restricted cash - money market accounts
|
169,235
|
|
|
169,235
|
|
|
—
|
|
|
—
|
|
||||
Total assets measured at fair value on a recurring basis
|
$
|
282,371
|
|
|
$
|
282,371
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Liabilities:
|
|
|
|
|
|
|
|
||||||||
Acquisition contingent consideration liability
|
$
|
1,259,531
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,259,531
|
|
Total liabilities measured at fair value on a recurring basis
|
$
|
1,259,531
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,259,531
|
|
Balance at December 31, 2015
|
$
|
1,259,531
|
|
Mark to estimated fair value recorded as general and administrative expense
|
(20,000
|
)
|
|
Balance at March 31, 2016
|
$
|
1,239,531
|
|
•
|
There is persuasive evidence of an arrangement;
|
•
|
The service has been or is being provided to the customer;
|
•
|
The collection of the fees is probable; and
|
•
|
The amount of fees to be paid by the customer is fixed or determinable.
|
|
March 31,
|
|
December 31,
|
||||
Country
|
2016
|
|
2015
|
||||
United States
|
$
|
38,291,092
|
|
|
$
|
38,935,928
|
|
International
|
24,616,088
|
|
|
24,831,027
|
|
||
Total long-lived assets
|
$
|
62,907,180
|
|
|
$
|
63,766,955
|
|
(3)
|
Acquisition
|
|
|
Three Months Ended
|
||
Supplemental pro forma information (unaudited):
|
|
March 31, 2015
|
||
Revenue
|
|
$
|
17,144,284
|
|
Net loss
|
|
(8,385,862
|
)
|
(4)
|
Consolidated Balance Sheet Components
|
|
March 31,
|
|
December 31,
|
||||
|
2016
|
|
2015
|
||||
Computer software and equipment
|
$
|
16,598,029
|
|
|
$
|
15,584,883
|
|
Software development costs
|
12,248,544
|
|
|
12,651,316
|
|
||
Furniture and fixtures
|
1,974,016
|
|
|
2,140,523
|
|
||
Leasehold improvements
|
2,945,018
|
|
|
3,081,861
|
|
||
Total property and equipment
|
33,765,607
|
|
|
33,458,583
|
|
||
Less: accumulated depreciation and amortization
|
(22,053,044
|
)
|
|
(21,278,474
|
)
|
||
Total property and equipment, net
|
$
|
11,712,563
|
|
|
$
|
12,180,109
|
|
|
March 31,
|
|
December 31,
|
||||
|
2016
|
|
2015
|
||||
Accrued bonus
|
$
|
2,516,351
|
|
|
$
|
1,843,719
|
|
Accrued commission
|
3,045,007
|
|
|
2,989,495
|
|
||
Deferred rent
|
226,583
|
|
|
230,224
|
|
||
Accrued severance
|
123,737
|
|
|
293,828
|
|
||
Accrued professional fees
|
682,924
|
|
|
815,893
|
|
||
Accrued taxes
|
789,896
|
|
|
705,032
|
|
||
Accrued contingent consideration and acquisition compensation
|
—
|
|
|
29,000
|
|
||
Other accrued expenses
|
2,065,527
|
|
|
1,897,968
|
|
||
Total
|
$
|
9,450,025
|
|
|
$
|
8,805,159
|
|
|
March 31,
|
|
December 31,
|
||||
|
2016
|
|
2015
|
||||
Current:
|
|
|
|
||||
Subscription revenue
|
$
|
30,159,287
|
|
|
$
|
28,766,188
|
|
Professional services revenue
|
1,327,821
|
|
|
1,455,578
|
|
||
Other
|
—
|
|
|
310,638
|
|
||
Total current
|
31,487,108
|
|
|
30,532,404
|
|
||
Noncurrent:
|
|
|
|
||||
Subscription revenue
|
358,811
|
|
|
375,244
|
|
||
Professional services revenue
|
1,979,828
|
|
|
2,018,101
|
|
||
Total noncurrent
|
2,338,639
|
|
|
2,393,345
|
|
||
Total deferred revenue
|
$
|
33,825,747
|
|
|
$
|
32,925,749
|
|
|
March 31,
|
|
December 31,
|
||||
|
2016
|
|
2015
|
||||
Deferred rent
|
$
|
1,952,930
|
|
|
$
|
1,732,607
|
|
Acquisition contingent consideration liability
|
1,239,531
|
|
|
1,230,531
|
|
||
Acquisition compensation costs
|
1,230,567
|
|
|
946,590
|
|
||
Total
|
$
|
4,423,028
|
|
|
$
|
3,909,728
|
|
(5)
|
Leases
|
|
Capital
Leases |
|
Operating
Leases |
||||
Remainder of 2016
|
$
|
1,315,165
|
|
|
$
|
3,522,630
|
|
2017
|
1,175,223
|
|
|
4,187,476
|
|
||
2018
|
506,395
|
|
|
3,096,591
|
|
||
2019
|
277,414
|
|
|
3,112,612
|
|
||
2020
|
100,399
|
|
|
2,295,700
|
|
||
2021 and thereafter
|
—
|
|
|
3,575,949
|
|
||
Total minimum lease payments
|
3,374,596
|
|
|
$
|
19,790,958
|
|
|
Less amount representing interest
|
(260,333
|
)
|
|
|
|||
Present value of net minimum capital lease payments
|
3,114,263
|
|
|
|
|||
Less current installments of obligations under capital leases
|
(1,559,760
|
)
|
|
|
|||
Obligations under capital leases excluding current installments
|
$
|
1,554,503
|
|
|
|
(6)
|
Debt
|
|
Principal
Payments |
||
Remainder of 2016
|
$
|
281,250
|
|
2017
|
656,250
|
|
|
2018
|
13,625,000
|
|
|
|
$
|
14,562,500
|
|
(7)
|
Stockholders' Equity
|
|
Shares
|
|
Amount
|
|||
Balance, December 31, 2015
|
26,260,459
|
|
|
$
|
26,261
|
|
Exercise of common stock options
|
68,758
|
|
|
69
|
|
|
Common stock issued for contingent consideration
|
6,506
|
|
|
6
|
|
|
Issuance of common stock for vested RSU's
|
11,264
|
|
|
11
|
|
|
Balance, March 31, 2016
|
26,346,987
|
|
|
$
|
26,347
|
|
(8)
|
Stock-based Compensation
|
|
Options
Outstanding |
|
Exercise Price
Per Share |
|
Weighted Average
Exercise Price |
||
Balance at December 31, 2015
|
4,402,943
|
|
|
$1.75 - $15.90
|
|
$9.38
|
|
Granted
|
248,728
|
|
|
3.74
|
|
3.74
|
|
Exercised
|
(68,758
|
)
|
|
$1.75 - $4.06
|
|
1.97
|
|
Canceled
|
—
|
|
|
—
|
|
—
|
|
Expired
|
(38,744
|
)
|
|
$1.75
|
|
1.75
|
|
Balance at March 31, 2016
|
4,544,169
|
|
|
$1.75 - $15.90
|
|
9.25
|
|
|
|
|
|
Options Outstanding
|
|
Options Exercisable
|
||||||||||||||||
Exercise Price Per Share
|
|
Options
Outstanding |
|
Weighted
Average Remaining Contractual Life |
|
Intrinsic
Value |
|
Options
Exercisable |
|
Weighted
Average Remaining Contractual Life |
|
Intrinsic
Value |
||||||||||
$
|
1.75
|
|
-
|
$ 2.68
|
|
763,175
|
|
|
4.0 years
|
|
$
|
2,321,046
|
|
|
729,775
|
|
|
3.9 years
|
|
$
|
2,229,864
|
|
$
|
2.74
|
|
-
|
$ 4.13
|
|
411,978
|
|
|
7.1 years
|
|
730,648
|
|
|
125,250
|
|
|
0.9 years
|
|
266,632
|
|
||
$
|
5.57
|
|
-
|
$ 9.06
|
|
1,194,878
|
|
|
8.5 years
|
|
—
|
|
|
428,644
|
|
|
8.1 years
|
|
—
|
|
||
$
|
12.62
|
|
-
|
$15.90
|
|
2,174,138
|
|
|
8.3 years
|
|
—
|
|
|
815,707
|
|
|
8.3 years
|
|
—
|
|
||
|
|
|
|
4,544,169
|
|
|
|
|
$
|
3,051,694
|
|
|
2,099,376
|
|
|
|
|
$
|
2,496,496
|
|
|
Number
of RSU's Outstanding |
|
Weighted Average
Grant Date Fair Value |
||
Balance at December 31, 2015
|
392,522
|
|
|
$8.07
|
|
Granted
|
635,410
|
|
|
3.74
|
|
Vested
|
(81,977
|
)
|
|
8.08
|
|
Canceled
|
—
|
|
|
—
|
|
Balance at March 31, 2016
|
945,955
|
|
|
5.16
|
|
(9)
|
Income Taxes
|
(10)
|
Net Loss Per Share
|
|
Three Months Ended
|
||||||
|
March 31,
|
||||||
|
2016
|
|
2015
|
||||
Basic and diluted net loss per share:
|
|
|
|
||||
Numerator:
|
|
|
|
||||
Net loss
|
$
|
(5,686,183
|
)
|
|
$
|
(6,950,176
|
)
|
Denominator:
|
|
|
|
||||
Weighted average shares used in computing net loss
|
26,440,343
|
|
|
25,959,332
|
|
||
Basic and diluted net loss per share
|
$
|
(0.22
|
)
|
|
$
|
(0.27
|
)
|
|
Three Months Ended
|
||||
|
March 31,
|
||||
|
2016
|
|
2015
|
||
Stock options outstanding
|
4,544,169
|
|
|
4,402,943
|
|
Restricted stock units
|
945,955
|
|
|
392,522
|
|
|
5,490,124
|
|
|
4,795,465
|
|
(11)
|
Commitments and Contingencies
|
•
|
although depreciation and amortization are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future, and adjusted EBITDA does not reflect cash capital expenditure requirements for such replacements or for new capital expenditure requirements;
|
•
|
adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs;
|
•
|
adjusted EBITDA does not reflect the potentially dilutive impact of equity-based compensation;
|
•
|
adjusted EBITDA does not reflect interest or tax payments that may represent a reduction in cash available to us; and
|
•
|
other companies, including companies in our industry, may calculate adjusted EBITDA differently, which reduces its usefulness as a comparative measure.
|
|
Three Months Ended
|
||||||
|
March 31,
|
||||||
|
2016
|
|
2015
|
||||
Net loss
|
$
|
(5,686,183
|
)
|
|
$
|
(6,950,176
|
)
|
Depreciation and amortization
|
1,683,162
|
|
|
1,556,956
|
|
||
Interest expense
|
200,380
|
|
|
124,933
|
|
||
Interest income
|
(21,628
|
)
|
|
(11,948
|
)
|
||
Income tax expense
|
72,354
|
|
|
102,275
|
|
||
EBITDA
|
(3,751,915
|
)
|
|
(5,177,960
|
)
|
||
Stock-based compensation
|
1,348,521
|
|
|
1,717,299
|
|
||
Puttable stock compensation
|
—
|
|
|
13,691
|
|
||
Change in fair value of contingent consideration liability
|
(20,000
|
)
|
|
(287,441
|
)
|
||
Purchase accounting deferred revenue adjustment
|
69,095
|
|
|
261,268
|
|
||
Acquisition compensation costs
|
283,977
|
|
|
136,911
|
|
||
Acquisition related costs
|
5,420
|
|
|
731,483
|
|
||
Adjusted EBITDA
|
$
|
(2,064,902
|
)
|
|
$
|
(2,604,749
|
)
|
|
Three Months Ended
|
||||||
|
March 31,
|
||||||
|
2016
|
|
2015
|
||||
Revenue:
|
|
|
|
||||
Subscription
|
$
|
12,438,984
|
|
|
$
|
10,341,350
|
|
Professional services
|
4,525,688
|
|
|
4,852,775
|
|
||
Total revenue
|
16,964,672
|
|
|
15,194,125
|
|
||
Cost of revenue:
|
|
|
|
||||
Cost of subscription revenue
|
5,049,875
|
|
|
4,388,240
|
|
||
Cost of professional services revenue
|
3,967,701
|
|
|
3,816,518
|
|
||
Total cost of revenue
|
9,017,576
|
|
|
8,204,758
|
|
||
Gross profit
|
7,947,096
|
|
|
6,989,367
|
|
||
Operating expenses:
|
|
|
|
||||
Sales and marketing
|
5,495,541
|
|
|
5,715,141
|
|
||
Research and development
|
3,887,996
|
|
|
3,625,719
|
|
||
General and administrative
|
3,998,636
|
|
|
4,383,423
|
|
||
Total operating expenses
|
13,382,173
|
|
|
13,724,283
|
|
||
Loss from operations
|
(5,435,077
|
)
|
|
(6,734,916
|
)
|
||
Interest income
|
21,628
|
|
|
11,948
|
|
||
Interest expense
|
(200,380
|
)
|
|
(124,933
|
)
|
||
Loss before income taxes
|
(5,613,829
|
)
|
|
(6,847,901
|
)
|
||
Income tax expense
|
72,354
|
|
|
102,275
|
|
||
Net loss
|
$
|
(5,686,183
|
)
|
|
$
|
(6,950,176
|
)
|
|
Three Months Ended
|
||||
|
March 31,
|
||||
|
2016
|
|
2015
|
||
Revenue:
|
|
|
|
||
Subscription
|
73
|
%
|
|
68
|
%
|
Professional services
|
27
|
|
|
32
|
|
Total revenue
|
100
|
|
|
100
|
|
Cost of revenue:
|
|
|
|
||
Cost of subscription revenue (1)
|
41
|
|
|
42
|
|
Cost of professional services revenue (1)
|
88
|
|
|
79
|
|
Total cost of revenue
|
53
|
|
|
54
|
|
Gross profit
|
47
|
|
|
46
|
|
Operating expenses:
|
|
|
|
||
Sales and marketing
|
32
|
|
|
38
|
|
Research and development
|
23
|
|
|
24
|
|
General and administrative
|
24
|
|
|
29
|
|
Total operating expenses
|
79
|
|
|
91
|
|
Loss from operations
|
(32
|
)
|
|
(45
|
)
|
Interest income
|
0
|
|
|
0
|
|
Interest expense
|
(1
|
)
|
|
(1
|
)
|
Loss before income taxes
|
(33
|
)
|
|
(46
|
)
|
Income tax expense
|
0
|
|
|
1
|
|
Net loss
|
(33
|
)%
|
|
(47
|
)%
|
(1) The table shows cost of revenue as a percentage of each component of revenue.
|
|
|
|
Revenue:
|
|
|
|
|
|
|
|
|||||||
|
Three Months Ended March 31,
|
|
Change
|
|||||||||||
|
2016
|
|
2015
|
|
$
|
|
%
|
|||||||
Subscription
|
$
|
12,438,984
|
|
|
$
|
10,341,350
|
|
|
$
|
2,097,634
|
|
|
20.3
|
%
|
Professional services
|
4,525,688
|
|
|
4,852,775
|
|
|
(327,087
|
)
|
|
(6.7
|
)%
|
|||
Total revenue
|
$
|
16,964,672
|
|
|
$
|
15,194,125
|
|
|
$
|
1,770,547
|
|
|
11.7
|
%
|
Cost of Revenue:
|
|
|
|
|
|
|
|
|||||||
|
Three Months Ended March 31,
|
|
Change
|
|||||||||||
|
2016
|
|
2015
|
|
$
|
|
%
|
|||||||
Cost of subscription revenue
|
$
|
5,049,875
|
|
|
$
|
4,388,240
|
|
|
$
|
661,635
|
|
|
15.1
|
%
|
Cost of professional services revenue
|
3,967,701
|
|
|
3,816,518
|
|
|
151,183
|
|
|
4.0
|
%
|
|||
Total cost of revenue
|
$
|
9,017,576
|
|
|
$
|
8,204,758
|
|
|
$
|
812,818
|
|
|
9.9
|
%
|
Operating Expenses:
|
|
|
|
|
|
|
|
|||||||
|
Three Months Ended March 31,
|
|
Change
|
|||||||||||
|
2016
|
|
2015
|
|
$
|
|
%
|
|||||||
Sales and marketing
|
$
|
5,495,541
|
|
|
$
|
5,715,141
|
|
|
$
|
(219,600
|
)
|
|
(3.8
|
)%
|
Research and development
|
3,887,996
|
|
|
3,625,719
|
|
|
262,277
|
|
|
7.2
|
%
|
|||
General and administrative
|
3,998,636
|
|
|
4,383,423
|
|
|
(384,787
|
)
|
|
(8.8
|
)%
|
|||
Total operating expenses
|
$
|
13,382,173
|
|
|
$
|
13,724,283
|
|
|
$
|
(342,110
|
)
|
|
(2.5
|
)%
|
Income Tax Expense:
|
|
|
|
|
|
||||||||
|
Three Months Ended March 31,
|
|
Change
|
||||||||||
|
2016
|
|
2015
|
|
$
|
|
%
|
||||||
Income tax expense
|
$
|
72,354
|
|
|
$
|
102,275
|
|
|
(29,921
|
)
|
|
(29.3
|
)%
|
|
Three Months Ended
|
||||||
|
March 31,
|
||||||
|
2016
|
|
2015
|
||||
Cash provided by (used in):
|
|
|
|
||||
Operating activities
|
$
|
3,054,385
|
|
|
$
|
(3,021,665
|
)
|
Investing activities
|
(694,957
|
)
|
|
(26,509,414
|
)
|
||
Financing activities
|
(2,109,125
|
)
|
|
20,432,628
|
|
||
|
|
|
|
||||
|
March 31,
|
|
December 31,
|
||||
|
2016
|
|
2015
|
||||
Cash and cash equivalents
|
$
|
17,599,856
|
|
|
$
|
17,854,523
|
|
Accounts receivable, net
|
$
|
15,250,744
|
|
|
$
|
18,308,547
|
|
|
AMBER ROAD, INC.
|
|
|
|
|
Date: May 9, 2016
|
By:
|
/s/ THOMAS E. CONWAY
|
|
|
Thomas E. Conway
|
|
|
Chief Financial Officer
|
|
|
(Principal Financial and Accounting Officer)
|
3.
|
Executive’s Duties and Obligations
.
|
4.
|
Devotion of Time to the Company’s Business
.
|
5.
|
Compensation and Benefits.
|
(i)
|
No fewer than 30 days prior to the Date of Termination, the Company provides Executive with written notice (the “Notice of Consideration”) of its intent to consider termination of Executive’s employment for Cause, including a reasonably detailed description of the acts or omissions that the Board believes constitute Cause;
|
(ii)
|
The Executive fails to cure the acts or omissions that constitute Cause within 30 days after receiving such Notice of Consideration;
|
(iii)
|
The Executive is provided an opportunity to appear before the Board, with or without legal representation, at Executive’s election, during the 30 day period following the Executive’s receipt of the Notice of Consideration to present arguments and evidence on his own behalf; and
|
(iv)
|
Following the presentation to the Board described in clause (iii) above or the Executive’s failure to appear before the Board at a
|
7.
|
Compensation and Benefits Payable Upon of Termination of Employment
.
|
(i)
|
the Executive’s accrued but unpaid Annual Bonus, if any, for the Fiscal Year ended prior to his Termination Date payable at the same time such annual bonuses for such Fiscal Year are paid to other key executives of the Company pursuant to the terms of the Key Executive Incentive Plan;
|
(ii)
|
100% of the Executive’s outstanding Equity Awards as of the Date of Termination will be fully vested and exercisable.
|
(i)
|
the Executive’s accrued but unpaid Annual Bonus, if any, for the Fiscal Year ended prior to his Termination Date payable at the same time annual bonuses for such Fiscal Year are paid to other key executives of the Company pursuant to the terms of the Key Executive Incentive Plan;
|
(ii)
|
if the Executive’s Date of Termination does not occur during the Post-Change of Control Period, the Executive shall receive a distribution or payment in settlement of each outstanding long-term performance-based Equity Award (including performance shares or other long-term Equity Awards that vest based on measures of long-term performance but excluding the Annual Bonus) for the applicable performance period in which Executive’s employment is terminated (pro-rated for
|
(iii)
|
if the Executive’s Date of Termination does not occur during the Post-Change of Control Period, (A) each outstanding unvested Equity Award (excluding Equity Awards described in Section 7(c)(ii)) will be vested in a portion equal to the greater of the number of shares underlying such Equity Award that would vest (x) if the Executive remained in continuous service with the Company for six (6) months following his Date of Termination, or (y) on the next applicable vesting date for such Equity Award (pro rated for the portion of the then current vesting period represented by the Executive's service through the Date of Termination), and (B) all of the Executive's vested stock options and stock appreciation rights after giving effect to clause (A) shall continue to be exercisable in accordance with the terms of the applicable Equity Award but in any event for not less than six (6) months after the Date of Termination (or until the original expiration date with respect to such Equity Award, if earlier);
|
(iv)
|
if the Executive’s Date of Termination occurs during the Post- Change of Control Period, 100% of the Executive’s outstanding Equity Awards as of the Date of Termination will be fully vested and exercisable and the period of time during which such Equity Awards may be exercised will be extended to the earlier of the date such Equity Awards would have terminated if the Executive was still employed or the third (3rd) anniversary of the Date of Termination;
|
(v)
|
a lump sum severance payment payable in a lump sum within five
|
(vi)
|
reimbursement of the COBRA premiums, if any, paid by the Executive for continuation coverage for the Executive, his spouse and dependents under the Company’s group health, dental and vision plans for the lesser of twenty-four (24) months or the maximum COBRA continuation period.
|
16.
|
Arbitration
.
|
(i)
|
The arbitrator shall have the sole authority to decide whether or not any Dispute between the parties is arbitrable and whether the party presenting the issues to be arbitrated has satisfied the conditions precedent to such party’s right to commence arbitration as required by this Section 16.
|
(ii)
|
The decision of the arbitrator, which shall be in writing and state the findings, the facts and conclusions of law upon which the decision is based, shall be final and binding upon the parties, who shall forthwith comply after receipt thereof. Judgment upon the award rendered by the arbitrator may be entered by any competent court. Each party submits itself to the jurisdiction of
|
(iii)
|
The arbitrator shall have the power to grant all legal and equitable remedies (including, without limitation, specific performance) and award compensatory and punitive damages if authorized by applicable law.
|
(iv)
|
Except as otherwise provided in Section 11 or by law, the parties shall bear their own costs in preparing for and participating in the resolution of any Dispute pursuant to this Section 16, and the costs of the arbitrator(s) shall be equally divided between the parties.
|
(v)
|
Except as provided in the last sentence of Section 16(a), the provisions of this Section 16 shall be a complete defense to any suit, action or proceeding instituted in any federal, state or local court or before any administrative tribunal with respect to any Dispute arising in connection with this Agreement. Any party commencing a lawsuit in violation of this Section 16 shall pay the costs of
|
18.
|
Miscellaneous
.
|
(d)
|
“Board” means the Board of Directors of the Company.
|
(e)
|
“Cause” means one or more of the following:
|
(i)
|
The Executive’s willful failure to perform his duties hereunder (other than as a result of illness or injury) that directly, materially and demonstrably impairs or damages the property, goodwill, reputation, business or finances of the Company;
|
(ii)
|
The Executive’s willful misconduct or gross negligence in the performance of his duties hereunder that directly, materially and demonstrably impairs or damages the property, goodwill, reputation, business or finances of the Company;
|
(iii)
|
The conviction of, or plea of
nolo contendere
by, the Executive to, a felony or a crime involving moral turpitude that materially and demonstrably impairs or damages the property, goodwill, reputation, business or finances of the Company; or
|
(iv)
|
The Executive’s commission of any willful acts of personal dishonesty in connection with his responsibilities as an employee of the Company that directly, materially and demonstrably impairs or damages the property, goodwill, reputation, business or finances of the Company.
|
(i)
|
any “person” (as defined in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934 (the “Exchange Act”)), other than the Company, any trustee or other fiduciary holding securities under an employee benefit plan of the Company, an underwriter temporarily holding securities pursuant to an offering of such securities or any corporation owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company, directly or indirectly (x) acquires “beneficial ownership” (as defined in Rule 13d-3 under the Exchange Act) of securities representing more than 50% of the combined voting power of the Company’s then outstanding securities or; (y) acquires within a twelve (12) consecutive month period “beneficial ownership” (as defined in Rule 13d-3 under the Exchange Act) of securities representing 35% of the combined voting power of the Company’s then outstanding securities;
|
(ii)
|
persons who comprise a majority of the Board are replaced during any twelve (12) consecutive month period by directors whose appointment or election is not endorsed by a majority of the members of the Board before the date of such appointment or election;
|
(iii)
|
the consummation of a reorganization, merger, statutory share exchange, consolidation or similar corporate transaction (each, a “Business Combination”) other than a Business Combination in which all or substantially all of the individuals and entities who were the beneficial owners of the Company’s voting securities immediately prior to such Business Combination beneficially own, directly or indirectly, 50% or more of the combined voting power of the voting securities of the entity resulting from such Business Combination (including, without limitation, an entity which as a result of the Business Combination owns the Company or all or substantially all of the Company’s assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership of the Company’s voting securities immediately prior to such Business Combination; or
|
(iv)
|
any “person” (as defined in Sections 13(d) and 14(d) of the Exchange Act) acquires all or substantially all of the assets of the Company within any twelve (12) consecutive month period.
|
(i)
|
the assignment to the Executive of any duties materially inconsistent with the Executive’s position, including any change in status, title, authority, duties or responsibilities or any other action which results in a material diminution in such status, title, authority, duties or responsibilities;
|
(ii)
|
a reduction in the Executive’s Base Salary by the Company or any breach by the Company of its obligations pursuant to Section 5(e) with respect to the Executive’s benefits;
|
(iii)
|
the relocation of the Executive’s office to a location more than 25 miles from East Rutherford, New Jersey;
|
(iv)
|
the failure of the Company to obtain the assumption in writing of the Company’s obligation to perform this Agreement by any successor to all or substantially all of the assets of the Company within 15 days after a Business Combination or a sale or other disposition of all or substantially all of the assets of the Company;
|
(v)
|
the requirement that the Executive report to any person other than the Board;
|
(vi)
|
any material reduction in the Company’s willingness or obligation to indemnify the Executive against liability for actions (or inaction, as the case may be) in his capacity as an officer, director or employee of the Company;
|
(vii)
|
a material breach of this Agreement by the Company; or
|
(viii)
|
the failure to nominate or elect the Executive to the Board.
|
1.
|
As a result of my Employment, I may come to possess Confidential Information, and the Company has informed me that it will not retain me unless I agree to the terms of this Agreement and abide by them. As used in this Agreement, "Confidential Information" includes, without limitation, information, whether or not in tangible form, which has not been publicly disclosed regarding Company, any of Company's customers, remarketing and/or support agreements made between Company and its business partners which disclose product data, commission rates, territories, quotas, and terms of licenses; the identities and locations of vendors and consultants furnishing materials and services to Company and the terms of such arrangements (including prices) negotiated by Company with such vendors and consultants; data relating to sales and license volumes, by customer, by location or by product; data relating to consulting agreements between Company and its customers which disclose billing rates, budgets, deliverables, time schedules and staff assignments; customer and product licensee and prospective product licensee lists; financial information that has not been released to the public by Company; employee lists of Company; future business plans, licensing strategies, advertising campaigns and the like; data provided to you which is marked as confidential or proprietary to Company, one of Company’s customers or business partners; proposed or actual acquisitions of stock or assets by Company; and/or any other information concerning or used in Company's business, its manner of operations, its plan, processes or other data.
|
2.
|
I will not at any time, except as required by my duties at Company, duplicate, remove, transfer, use, disclose or communicate, or knowingly allow any other person to duplicate, remove, transfer, use, disclose or communicate, any Confidential Information. I will safeguard all Confidential Information at all times so that it is not exposed to, or taken by, unauthorized persons and will exercise my best efforts to assure its safekeeping. I understand that the maintenance of the confidentiality of Confidential Information is material and essential to Company and its disclosure would have a severe adverse effect on the conduct of Company's business, and Company's competitive position and goodwill.
|
3.
|
Upon termination of my Employment, whether voluntary or involuntary, or upon Company's request at any time during the term of my Employment, I will deliver to Company all written and other materials which contain or relate to Confidential Information, whether formal or informal, whether prepared by me or by
|
4.
|
I will not make any unauthorized disclosure of trade secrets or confidential information to any third person, including any such information which is subject to a confidentiality agreement between Company and such third person, to which I gain access as a result of my Employment.
|
5.
|
My obligations under this Agreement will remain in effect both during the term of my Employment and thereafter, whatever the reason for termination of my Employment, and shall survive any termination of this Agreement.
|
6.
|
(a) All intellectual property in whatever form including, without limitation, inventions, discoveries, ideas, computer programs, programs based upon or developed from computer programs, improvements, codes, methods, algorithms, trade secrets, know-how, system documentation, technical data, drawings, flow charts, prototypes, design specifications, and any other documentation, notes and materials related to the foregoing (whether or not patentable or copyrightable) that are conceived or made by me, either alone or with others, during the course of or derived from my Employment by Company and in any way related to my Employment or to any business in which Company is engaged at any time during the term of my Employment or (if it should reasonably be known by me) is considering in engaging ("Discoveries"), shall be deemed to be "works made for hire" if permitted by applicable law and shall belong to Company.
|
(b)
|
I will promptly disclose all Discoveries to Company.
|
(c)
|
To the extent that any Discovery does not constitute a work made for hire pursuant to applicable law, I hereby transfer, grant, convey, assign and relinquish exclusively to Company all of my rights to, title to and interest in all Discoveries, in perpetuity (or for the longest period of time otherwise permitted by law), including:
|
(i)
|
all of my rights, title, interest, and benefit (including the right to make, use, or sell under patent law; to copy, adapt, distribute, display, and perform under copyright law; and to use and disclose under trade secret law) in and to all United States and foreign patents and patent applications, patent license rights, patentable inventions, trade secrets, trademarks, service marks, trade names (including, in the case of trademarks, service marks and trade names, all goodwill pertaining thereto), copyrights, technology licenses, know-how, confidential information, shop rights, and all other intellectual property rights owned or claimed or acquired in the future by me as embodied in the Discoveries; and
|
(ii)
|
all of my rights, title, interest, and benefit and all powers and privileges, in, to, and under all technical data, drawings, prototypes, engineering files, system documentation, flow charts, and design specifications developed by, owned, or acquired previously or in the future by me in connection with the development of the programming, inventions, processes, and apparatus entailed by the Discoveries.
|
(d)
|
I will execute and deliver, from time to time after the date hereof, upon Company's request, such further conveyance instruments, and take such further actions, as may be necessary or desirable to evidence more fully the transfer of ownership of all the Discoveries to Company, or the original ownership of all the Discoveries on the part of Company, to the fullest extent possible. I therefore agree to:
|
(i)
|
execute, acknowledge, and deliver any affidavits or documents of assignment and conveyance regarding the Discoveries.
|
(ii)
|
provide testimony in connection with any proceeding affecting the right, title, interest, or benefit of Company in or to the Discoveries.
|
(iii)
|
perform any other acts deemed necessary to carry out the intent of this Agreement including, without limitation, assisting in the application, perfection, maintenance and enforcement of the Discoveries and all rights relating thereto.
|
(e)
|
In furtherance of this Agreement, I hereby acknowledge that, from this date forward, or a
previous date if rights were earlier transferred, Company has succeeded to all of my rights, title, and standing to:
|
(i)
|
receive all rights and benefits pertaining to the Discoveries.
|
(ii)
|
institute and prosecute all suits and proceedings and take all actions that Company, in its sole discretion may deem necessary or proper to collect, assert, or enforce any claim, right, or title of any kind in and to any and all of the Discoveries.
|
(iii)
|
defend and compromise any and all such actions, suits, or proceedings relating to such transferred and assigned rights, title, interest, and benefits, and do all other such acts and things in relation thereto as Company, in its sole discretion, deems advisable.
|
(f)
|
Upon termination of my Employment, I will immediately surrender to Company all materials and work product in my possession or within my control (including all copies thereof) relating in any way to the Discoveries.
|
(g)
|
To effectuate the terms of this paragraph 6, I hereby name and irrevocably constitute and appoint Company, with the full power of substitution therein, as my true and lawful attorney-in-fact to exercise the rights assigned hereby.
|
(h)
|
I represent and warrant that no consents of any other parties are necessary or appropriate under any agreements concerning any of the Discoveries in order for the transfer and assignment of any of the Discoveries under this Agreement to be legally effective.
|
(i)
|
I represent and warrant that, to the best of my knowledge, upon consummation of this Agreement, Company will have good and marketable title to the Discoveries, free and clear of any and all liens, mortgages, encumbrances, pledges, security interests, or charges of any nature whatsoever.
|
7.
|
I have listed on the Schedule attached to this Agreement all inventions, if any, conceived or made by me prior to my Employment by Company and which are to be excluded from this Agreement, as well as any restrictions on any work for Company or any obligations under this Agreement arising from any prior employment or other agreement. I am not required to list on the Schedule any inventions conceived or made by me prior to my Employment by Company that (i) are unrelated to the business, operations, services or products of Company or (ii) are solely related to my personal hobbies and not to the business, operations, service or products of Company.
|
8.
|
I agree that all Company relationships, whether or not contractual, including but not limited to, relationships with employees, contractors, consultants, partners (collectively “Relationships”) are the sole property of Company. I agree that, during and after my Employment with Company, unless Company provides written consent, I will not directly or indirectly provide information, including but not limited to,
|
9.
|
I agree that all Company relationships with customers, partners, resellers, vendors and suppliers and all information, whether or not in writing, are and shall be the exclusive property of Company (collectively "Customer Information"). Customer Information shall not be used outside the duties of my Employment with Company without the written consent of Company, either during or after the termination of my Employment with Company.
|
10.
|
(a) I further agree that, during the term of my Employment with Company, and for a period of twenty-four months following the termination (whether voluntary or involuntary) of such Employment, I will not engage in any capacity (including without limitation, as an employee, officer, director, consultant or shareholder (other than as an owner of 1% or less of the outstanding shares of any publicly-traded company), in any Competing Business in any geographical area in which Company (or any of Company’s affiliates) transacts such business. For purposes of this Agreement a “Competing Business” means any business engaged in providing services similar to Company’s or in the marketing, sale, development and distribution of products that are similar to Company's.
|
(b)
|
The covenants contained in this Section 10 shall be enforced to the fullest extent permissible under the laws of each jurisdiction in which enforcement is sought. Accordingly, I agree that if any of the provisions of this Section 10 shall be adjudicated to be invalid or unenforceable for any reason whatsoever, said provision shall be construed (only with respect to the operation thereof in the particular jurisdiction in which such adjudication is made) by limiting and reducing it so as to be enforceable to the fullest extent permissible, without invalidating the remaining provisions of this Agreement or affecting the validity or enforceability of said provision in any other jurisdiction.
|
11.
|
Breach by me of any provision of this Agreement will cause Company irreparable injury and damage for which money damages may not be adequate. In addition to all other remedies that are available to it, Company shall be entitled to preliminary and permanent injunctive and equitable relief to prevent or remedy a breach of this Agreement by me.
|
12.
|
This Agreement:
|
(a)
|
shall bind my heirs, executors, administrators, legal representatives and assigns, and supersedes any prior agreements concerning Confidential Information executed by me with or in favor of Company, if any.
|
(b)
|
constitutes the entire understanding between Company and me concerning Confidential Information and no waiver or amendment of any provision of this Agreement shall be valid or effective unless in writing and signed by the party against whom enforcement thereof is sought.
|
(c)
|
shall be enforceable by Company or any of its successors or assigns.
|
(d)
|
shall be enforced and construed in accordance with the laws of the State of New Jersey, without giving effect to the choice of laws principles of New Jersey that would result in the application of the laws of any other jurisdiction.
|
13.
|
Should any part of this Agreement for any reason be declared by any court of competent jurisdiction to be invalid, that decision shall not affect the validity of the remaining portion, which shall continue in full force and effect as if this Agreement had been executed with the invalid portion eliminated, provided, however, that this Agreement shall be interpreted to carry out to the greatest extent possible the intent of the parties and to provide to Company substantially the same benefits as Company would have received under this Agreement if such invalid part of this Agreement had been enforceable.
|
14.
|
I represent that I am not a party to, or bound by, any confidentiality agreements, non-compete agreements, restrictive covenants, non-solicitation agreements, invention and assignment agreements, or any other agreements or obligations to any former employer or other entity that will prevent me from performing, or impede me in performance of service for Company. I also represent that I have disclosed to Company all contracts or agreements that could prevent me from carrying out my responsibilities for Company. I further acknowledge that I have not and will not take or remove from my prior employment the originals or copies of any documents maintained as confidential or proprietary information by my prior employer, and that I have not and will not disclose any confidential or proprietary information of my prior employer. Therefore, I am “free and clear” to be employed by Company. I acknowledge that Company is relying on my representation in making its offer of employment, in employing me, or in continuing my employment with Company. I further agree not to enter into any agreement either written or oral in conflict with my Employment with Company.
|
15.
|
I further agree that this Agreement does not constitute a contract of employment, and that I have the right to resign and Company has the right to terminate my employment at any time, for any reason, with or without cause, subject to the provisions of any written employment agreement between Company and me. I hereby acknowledge that I have read this Agreement, understand it and agree to be bound by its restrictions.
|
(i)
|
Any claims for benefits under employee benefit plans in accordance with the terms of the applicable employee benefit plan, including the Executive’s right to elect continuation coverage under the Company’s group health, dental and/or visions plans pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (COBRA),
|
(ii)
|
Any right to exercise stock options or stock appreciation rights that were vested and exercisable on the Date of Termination in accordance with the terms thereof (as modified by the Employment Agreement);
|
(iii)
|
Any Claim under or based on a breach of the Company’s obligations to pay the compensation and benefits described in Sections 5 or 7(a) or (c) of the Employment Agreement,
|
(iv)
|
Rights or Claims that may arise under the Age Discrimination in Employment Act after the date that Executive signs this Release,
|
(v)
|
Any right to indemnification by the Company or to coverage under directors and officers liability insurance to which Executive is otherwise entitled in accordance with Section 12 of Employment or the Company’s articles of incorporation or by-laws or other agreement between the Executive and the Company.
|
1.
|
I have reviewed this
Quarterly Report on Form 10-Q
of Amber Road, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(c)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: 5/9/2016
|
/s/ JAMES W. PREUNINGER
|
|
James W. Preuninger
|
|
Chief Executive Officer and Director
|
|
(Principal Executive Officer)
|
1.
|
I have reviewed this
Quarterly Report on Form 10-Q
of Amber Road, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(c)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: 5/9/2016
|
/s/ THOMAS E. CONWAY
|
|
Thomas E. Conway
|
|
Chief Financial Officer
|
|
(Principal Financial Officer)
|
(1)
|
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
(2)
|
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date: 5/9/2016
|
/s/ JAMES W. PREUNINGER
|
|
James W. Preuninger
|
|
Chief Executive Officer and Director
|
|
(Principal Executive Officer)
|
(1)
|
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
(2)
|
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date: 5/9/2016
|
/s/ THOMAS E. CONWAY
|
|
Thomas E. Conway
|
|
Chief Financial Officer
|
|
(Principal Financial Officer)
|